ANKRD20A7P

Across TCGA pan-cancer cohorts, ANKRD20A7P RNA differs between tumor and matched normal tissue in 10 of 18 cancer types tested, making tumor–normal expression one of ANKRD20A7P’s most consistent transcriptional readouts.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where ANKRD20A7P RNA is repressed in tumor relative to normal tissue. In most cancer types ANKRD20A7P is over-expressed in tumor, although a few such as HNSC and BRCA show the opposite, repressed pattern.

HNSC, KIRC, and BRCA are the cancer types where ANKRD20A7P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in ANKRD20A7P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
HNSC	All	All	−0.136	<.001	11	view →
KIRC	All	All	+0.280	<.001	8	view →
BRCA	Female	II,III,IV	−0.215	<.001	6	view →
UCEC	All	II,III,IV	−0.128	.002	6	view →
LUAD	All	IV	−0.115	.001	6	view →
LUSC	Female	All	−0.237	<.001	5	view →
KIRP	All	All	+0.296	.015	4	view →
THCA	All	III,IV	−0.221	.036	2	view →
KICH	All	All	−0.137	.021	2	view →
COAD	All	II,III,IV	−0.069	.043	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 10 strongest of 10 lineages.

ANKRD20A7P–HNSC

Open the HNSC breakdown →